Ho, A. and Fox, R. (2011) Tailoring response-based treatment for hepatitis C. Viral Hepatitis in Practice, 3(1), pp. 1-5.
Full text not currently available from Enlighten.
Publisher's URL: http://www.vhip.co.uk/_year_search_review.aspx?JID=10&Year=2011&Edition=133
Abstract
The recommended treatment for chronic infection with hepatitis C virus (HCV) is a combination of pegylated interferon (pegIFN) alfa and ribavirin (RBV). Treatment duration is determined by HCV genotype: in genotype 1 (G1) infection, treatment usually lasts for 48 weeks, whereas in genotypes 2 and 3 (G2, G3), therapy for 24 weeks has been found to have equivalent efficacy.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Ho, Dr Antonia |
| Authors: | Ho, A., and Fox, R. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research |
| Journal Name: | Viral Hepatitis in Practice |
| Publisher: | Hayward |
| ISSN: | 2041-1162 |
| ISSN (Online): | 2045-7863 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details